EUROAPI supports Sanofi’s mRNA vaccine platform with the development of lipid nanoparticles EUROAPI, the European CDMO announced by Sanofi in February 2020, has expanded its collaboration with the French group under the umbrella of their Master Agreement for Development and GMP Manufacturing Services, dated October 1, 2021, to support…..
